Conclusions the local infusion chemotherapy via hepatic artery and portal vein was an effective therapy for those who could not undergo the resection of advanced liver cancer.
结论肝动脉局部灌注化疗对不能手术切除的晚期肝癌，作为治疗手段不失为一种有效的方法。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗，可以改善临床症状、延长存活期。
Methods: 49 patients with late liver carcinoma were treated with embolism of hepatic artery and combined with chemotherapy through portal vein were reported.
方法：49 例无手术指征肝癌患者，行单纯肝动脉栓塞与在肝动脉栓塞的基础上行肝门静脉化疗的对照研究。
Objective To investigate the application of local treatment combining with chemotherapy via portal vein guided by US in advanced hepatic cancer.
目的探讨超声引导下局部治疗结合门静脉化疗在中晚期肝癌中的应用。
Objective To explore the curative effect of double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma.
目的探讨肝动脉、门静脉双重插管区域灌注化疗在中晚期不能切除原发性肝癌应用方法及临床疗效。
Objective To investigate the clinical value about hepatic arterial chemoembolization and portal vein continuous perfusion chemotherapy in the treatment of primary liver cancer.
目的探讨肝动脉化疗栓塞加门静脉持续灌注化疗治疗原发性肝癌的临床价值。
Methods From Jan 1996 to Nov 2000, the hepatic artery and portal vein intubation chemotherapy were used in 16 cases with unresectable liver cancer.
方法对16例不能切除的肝癌采用肝动脉，门静脉同时插管化疗。
Methods From Jan 1996 to Nov 2000, the hepatic artery and portal vein intubation chemotherapy were used in 16 cases with unresectable liver cancer.
方法对16例不能切除的肝癌采用肝动脉，门静脉同时插管化疗。
应用推荐